COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 135 filers reported holding COGENT BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,700,006 | -17.7% | 3,558,975 | 0.0% | 4.18% | -29.7% |
| Q2 2023 | $42,138,264 | +41.5% | 3,558,975 | +29.0% | 5.94% | +16.0% |
| Q1 2023 | $29,769,340 | -6.7% | 2,758,975 | 0.0% | 5.12% | +1.2% |
| Q4 2022 | $31,893,751 | -22.5% | 2,758,975 | 0.0% | 5.06% | -30.1% |
| Q3 2022 | $41,164,000 | +65.4% | 2,758,975 | 0.0% | 7.24% | +27.0% |
| Q2 2022 | $24,886,000 | +113.1% | 2,758,975 | +77.0% | 5.70% | +106.3% |
| Q1 2022 | $11,677,000 | -12.7% | 1,558,975 | 0.0% | 2.76% | -37.4% |
| Q4 2021 | $13,376,000 | +2.0% | 1,558,975 | 0.0% | 4.41% | -7.5% |
| Q3 2021 | $13,111,000 | +3.7% | 1,558,975 | 0.0% | 4.77% | -8.3% |
| Q2 2021 | $12,643,000 | -7.6% | 1,558,975 | 0.0% | 5.20% | -9.9% |
| Q1 2021 | $13,688,000 | -21.8% | 1,558,975 | 0.0% | 5.77% | -7.8% |
| Q4 2020 | $17,507,000 | – | 1,558,975 | – | 6.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,558,975 | $17,507,000 | 6.26% |
| COMMODORE CAPITAL LP | 760,025 | $8,535,000 | 4.64% |
| Ally Bridge Group (NY) LLC | 1,622,591 | $18,222,000 | 3.12% |
| Ghost Tree Capital, LLC | 1,100,000 | $12,353,000 | 2.75% |
| Logos Global Management LP | 1,920,500 | $21,567,000 | 1.85% |
| Altium Capital Management LP | 432,563 | $4,858,000 | 1.81% |
| VR Adviser, LLC | 1,088,817 | $12,227,000 | 1.80% |
| Atlas Venture Associates IX, LLC | 916,196 | $10,289,000 | 1.63% |
| Atlas Venture Associates XI, LLC | 916,196 | $10,289,000 | 1.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 235,066 | $2,640,000 | 1.53% |